Connect with us

Artificial Intelligence

Research Antibodies Market To Reach USD 5.33 Billion By 2027 | Reports and Data

GlobeNewswire

Published

on

New York, June 29, 2020 (GLOBE NEWSWIRE) — The global research antibodies market is expected to reach USD 5.33 Billion by 2027, according to a new report by Reports and Data. Rising research activities in the field of stem cells is a significant factor driving the growth of the market. Stem cells have the capability of discerning and regenerating various kinds of cells in the human body. These cells possess the potential to cure life-threatening diseases such as oncological and blood-related disorders. Cord blood stem cells find application in the treatment of more than 80 blood-related ailments, such as Sickle Cell Disease. It is projected that over 27 million babies across the globe are born with some kind of blood disorder. As per the World Health Organization, in 2008, 100,000 children were found to be suffering from thalassemia in India.Increased funding for research and development activities is instrumental in driving the growth of the market. Investment in the healthcare R&D by the US has witnessed a growth of 18.1% between the years 2014 and 2017. In the year 2017, in the US, the overall expenditure on healthcare R&D was USD 182.30 billion. Besides, according to the 2016 financial statements of Celgene Corporation, a leading biopharmaceutical firm, the R&D expenditure grew by USD 772.8 million (21.0% more than 2015 expenses) in 2016 to USD 4.47 billion. Also, a USD 892.9 million of R&D asset acquisition spending, comprising a USD 625.0 million purchase of Engmab AG, a private firm engaged in T-cell bispecific antibodies, added to the overall R&D expenses of the Celgene.However, cost-prohibitive research antibodies and issues related to the quality of nontherapeutic antibodies may create hindrances in the growth of the market in the upcoming years.Get FREE Sample Copy with TOC of the Report to understand the structure of the complete report@ https://www.reportsanddata.com/sample-enquiry-form/3270COVID-19 Impact
As the global economies are experiencing the negative impact of the Covid-19 pandemic, organizations are suffering losses, among various other challenges. Nevertheless, firms in the pharmaceutical industry are of immense importance in combatting the pandemic and are witnessing positive growth in the contagious disease landscape with the race for treatment approval therapy gaining momentum.
In April 2020, the ICMR (Indian Council of Medical Research) announced that it would fast-track funding proposals intended for immunology approaches for the treatment of coronavirus, a step to bridge the research gap in the country to combat the pandemic.Further key findings from the report suggestBy product, primary antibodies held a larger market share in 2019. Primary antibodies are those, which bind to the antigen, protein, or any substance that is intended to be studied. Primary antibodies, in immunoassays, are of prime importance to bind to the target antigen.By technology, western blotting contributed to the largest market share in 2019. The benefits of western blots comprise the capacity to detect picogram levels of protein in a sample, enabling it to be used for several applications such as an effective early diagnostic tool. Also, it lets researchers for direct labeling of primary antibodies, therefore removing the requirement of secondary antibodies.By application, oncology contributed to the largest market share in 2019. Antibody-based treatment of cancer is considered as an effective therapeutic approach for both hematologic solid tumors and malignancies. Antibodies are also beneficial in using the human immune system to fight cancer.The market in the Asia Pacific region is expected to grow at the fastest rate of 7.1% in the forecast period. The high growth of the APAC region is owing to the growth of the pharmaceutical industry, surge in R&D activities for antibodies, and acceptance of innovative methods for antibody production, among others.Key participants include Becton, Dickinson and Company, Lonza Group, Agilent Technologies, Abcam PLC, PerkinElmer, Inc., Bio-Rad Laboratories, Merck Millipore, F.Hoffmann-La Roche AG, Thermo Fisher Scientific, and Cell Signaling Technology Inc., among others.In January 2020, Abcam PLC, a leading market player, made an announcement about the acquisition of the Immunology and Proteomics business of Expedeon that comprises Innova and TGR Biosciences.BUY NOW (Customized Report Delivered as per Your Specific Requirement)@ https://www.reportsanddata.com/checkout-form/3270For the purpose of this report, Reports and Data have segmented the global research antibodies market on the basis of product, antibody type, technology, application, end-users, and region:Product Outlook (Revenue, USD Million; 2017-2027)Primary AntibodiesSecondary AntibodiesAntibody Type Outlook (Revenue, USD Million; 2017-2027)MonoclonalPolyclonalTechnology Outlook (Revenue, USD Million; 2017-2027)Western BlottingFlow CytometryImmunofluorescenceImmunohistochemistryEnzyme-linked Immunosorbent AssayImmunoprecipitationOthersApplication Outlook (Revenue, USD Million; 2017-2027)OncologyInfectious DiseasesStem CellsNeurobiologyImmunologyOthersIndustry Vertical Outlook (Revenue, USD Million; 2017-2027)Pharmaceutical & BiopharmaceuticalAcademic & Research InstitutesContract Research OrganizationsTo identify the key trends in the industry, click on the link below:   https://www.reportsanddata.com/report-detail/research-antibodies-marketRegional Outlook (Revenue, USD Million; 2017-2027)North AmericaU.SCanadaEuropeGermanyUKFranceBeneluxRest of EuropeAsia PacificChinaIndiaJapanSouth KoreaRest of Asia PacificLatin AmericaBrazilRest of Latin AmericaMEASaudi ArabiaUAERest of Middle East and AfricaTake a Look at our Related Reports:E-Prescribing Market: https://www.reportsanddata.com/report-detail/e-prescribing-marketMobile Health (mHealth) Market: https://www.reportsanddata.com/report-detail/mobile-health-mhealth-marketArtificial Intelligence in Drug Discovery Market: https://www.reportsanddata.com/report-detail/artificial-intelligence-in-drug-discovery-marketAbout Reports and DataReports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Datametrex Announces Another Sale of COVID-19 Test Kits for $850,000 to a Canadian Mining Company

GlobeNewswire

Published

on

TORONTO, July 06, 2020 (GLOBE NEWSWIRE) — Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce a purchase order (the “PO”) of 20,000 COVID-19 test kits from a Canadian based mining company (the “Purchaser”) with operations worldwide. This PO is for one of their Latin American mine operations.
The total gross sales amount is approximately $850,000 CDN, excluding shipping and courier fees. The Company has secured all requested testing kits, swabs, tubes, and the PCR machines. All of the items will be delivered directly to the mining company at their operating site in Latin America in mid-July. The Company anticipates little or no up front costs associated with the sale of these kits.“Datametrex is assisting with the implementing of test kits as it is a fundamental response to the pandemic, and those mining companies that have been able to test more comprehensively have had greater success,” says Marshall Gunter, CEO of the Company. “The reasoning is simple: An individual who tests positive can be isolated until they recover, and their contacts may be traced and similarly tested and isolated, effectively reducing the rate of transmission.”Under the terms of the PO, Datametrex will provide the Purchaser with 20,000 units of the COVID-19 qPCR Detection Kits manufactured by 1drop Inc. (“1drop”), 20,000 Universal Transport Medium (UTM®), Sterile Swabs with 16x100mm and Skirted Tubes. The Company also sold two (2) Real-Time Polymerase Chain Reaction Detection System (“PCR”) machines along with software to ensure optimal assay performance of the samples.Some Latin American countries are seeing shocking unemployment figures as the pandemic has caused hunger to rise in the region. The fallout from the pandemic is being felt hardest in Latin America, and has seen an almost three-fold rise in the number of people requiring government assistance, and among urban communities in low and middle-income countries, which are being dragged into destitution by job losses, especially in the mining sector. Millions of people are out of work in Brazil, Chile and Colombia, which have all attempted to re-open sectors of their economies but were hit with fast-spreading infections.About 1drop Inc.1drop Inc. aims to provide a solution to manage health with a drop of fluid. It has the key technologies for becoming a global leading company in the field of smart health care. 1copy™ COVID-19 qPCR Multi Kit can reduce the risk of asymptomatic and latent infection of COVID-19 by a single virus level limit of detection. Additional information on 1drop Inc. is available at www.1drop.co.krAbout DatametrexDatametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational Health and Safety goals with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain.Additional information on Datametrex is available at www.datametrex.comFor further information, please contact:Marshall Gunter – CEO
Phone: (514) 295-2300
Email: mgunter@datametrex.com
Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.Forward-Looking StatementsThis news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Continue Reading

Artificial Intelligence

Gained Traction over the Past Few Years due the Rising Need for Energy Efficient Solutions in the Residential Sectors: Global Smart Thermostats Market

GlobeNewswire

Published

on

Covina, CA, July 06, 2020 (GLOBE NEWSWIRE) —The global smart thermostats market accounted for US$ 1.5 billion in 2019 and is estimated to be US$ 12.5 billion by 2029 and is anticipated to register a CAGR of 23.5%The report “Global Smart Thermostats Market, By Component (Display, Motion Sensor, Humidity Sensor, Temperature Sensor, and Others), By Network Technology (Wired Technology and Wireless Technology (Wi-Fi, Z-Wave, Zigbee, and Bluetooth)), By Application (Residential, Commercial, Industrial, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) – Trends, Analysis and Forecast till 2029”.Key Highlights:Nest Labs, Inc. offers networking products. The Company designs and manufactures a sensor-driven, Wi-Fi enabled, learning, and programmable thermostat. Nest Labs operates in the United States.Emerson Electric Co. designs and manufactures electronic and electrical equipment, software, systems, and services. The Company offers its products for industrial, commercial, and consumer markets worldwide through its network power, process management, industrial automation, climate technologies, and commercial and residential solutions divisions.Request Sample PDF of this Business Intelligence Report @ https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4376Analyst View:Speedy adoption of smart infrastructure in commercial and residential infrastructureTechnological advancements and shift in population towards convenient methods to remotely control electronic and electrical appliances drives the demand of the smart infrastructure. A smart thermostat is a device that is fitted in a smart infrastructure to provide users remote access to ambience heating or temperature. This offers benefits of switching heating systems through internet connected devices. Additionally, smart thermostats can also be arranged as per the need of users, which brings energy efficiency by limiting human error and negligence at times, which aids in the growth of smart thermostat market growth worldwide.Penetration of IoT and AI based technologiesAdvancements in IoT and AI has modernized electronic systems and devices. Additionally, the adoption of artificial intelligence in thermostats has advanced programmable thermostats to smart ones. Smart thermostat provides self-learning abilities and learn the user behavior over time. Thereby, automatically regulating temperature of the atmosphere. Smart thermostats are designed for connection over Wi-Fi and further advancements in these smart devices provides access to them via voice control, which boosts smart thermostat market growth across the globe.Ask for a Discount on the Current Pricing @ https://www.prophecymarketinsights.com/market_insight/Insight/request-discount/4376Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Smart Thermostats Market”, By Component (Display, Motion Sensor, Humidity Sensor, Temperature Sensor, and Others), By Network Technology (Wired Technology and Wireless Technology (Wi-Fi, Z-Wave, Zigbee, and Bluetooth)), By Application (Residential, Commercial, Industrial, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) – Trends, Analysis and Forecast till 2029Key Market Insights from the report:        The global smart thermostats market accounted for US$ 1.5 billion in 2019 and is estimated to be US$ 12.5 billion by 2029 and is anticipated to register a CAGR of 23.5%. The market report has been segmented on the basis of component, network technology, application, and region.By component, the global smart thermostats market is segmented into display, motion sensor, humidity sensor, temperature sensor, and others.By network technology, wireless technology is projected to offer great growth opportunity for the growth of global smart thermostat sensor market. Wireless network technology is further sub segmented into Wi-Fi, Z-Wave, Zigbee and Bluetooth.By application, commercial application segment involves healthcare, office building, and retail etc. Other Segment involves educational buildings such as school and colleges. Among all these application, residential applications are projected to grow expressively in the coming years due to the rising awareness about energy saving devices among consumers, advancement in home automation technology, and increasing demand of connected homes or smart homes.By region, The North American regional market is projected to lead the global industry owing to growing demand for managing energy consumption solutions and a wide distribution network of key manufacturers in the region. The rising average unit rate of power is inspiring household consumers, industries, and enterprises to implement smart energy solutions, which is one of the basic reasons for the market growth.To know the upcoming trends and insights prevalent in this market, click the link below:https://www.prophecymarketinsights.com/market_insight/Global-Smart-Thermostats-Market-4376Competitive Landscape:The prominent player operating in the global smart thermostats market includes Nest Labs, Inc., Emerson Electric Co., Ecobee Inc., Hive Home, Tado GmbH, Schneider Electric, Honeywell International Inc., Carrier Corporation, Siemens, Emerson Electric, and Vivint.The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.About Prophecy Market InsightsProphecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.Some Important Points Answered in this Market Report Are Given Below:Explains an overview of the product portfolio, including product development, planning, and positioningExplains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.Detailed analysis of the market revenue over the forecasted period.Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.Study on the segments that are anticipated to dominate the market.Study on the regional analysis that is expected to register the highest growth over the forecast periodKey Topics CoveredIntroductionStudy DeliverablesStudy AssumptionsScope of the StudyResearch MethodologyExecutive SummaryOpportunity Map AnalysisMarket at GlanceMarket Share (%) and BPS Analysis, by RegionCompetitive LandscapeHeat Map Analysis Market Presence and Specificity AnalysisInvestment AnalysisCompetitive AnalysisBROWSE RELATED REPORTS:Global DINRail Thermostats MarketGlobal Commercial Vehicle Thermostat MarketTo know more Contact Us:
Sales
Prophecy Market Insights Email- sales@prophecymarketinsights.com

Continue Reading

Artificial Intelligence

Patriot One Provides PATSCAN™ Platform Update

GlobeNewswire

Published

on

TORONTO, July 06, 2020 (GLOBE NEWSWIRE) — Patriot One Technologies Inc. (TSX: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) (“Patriot One” or the “Company”), offers the latest update on its PATSCAN™ Multi-Sensor Threat Detection Platform.
In May 2020, Patriot One’s Product Development Team responded to the Covid19 Pandemic as part of the Canadian Digital Technology Supercluster Covid19 Program.  The Company secured up to $4.5 million (CAD) in co-investment funding under a two-stage program that includes development and deployment of (i) a thermal screening module that highlights persons presenting with elevated temperatures in real-time, using commodity-priced thermal cameras, (ii) additional computer modules that detect the presence or non-presence of medical and non-medical masks and face coverings, and the ability to highlight persons and problem areas where social distance requirements are not being maintained, and (iii) cross-location temperature monitoring to help the prediction of future outbreaks based on the overall trending and the combination of quantifiable indicators. Stage One comprises up to $2.25 million in investment to demonstrate the development of the modules over a four to six-month timeframe with on-site deployments with five or more co-development customers.  In Stage Two, Patriot One will receive a second investment advance of up to $2.25 million over a six to eight-month timeframe to refine the Health & Safety Modules and redeploy with Stage One partners and customer(s). Patriot One’ s new Health & Safety modules are additional video object recognition solutions that are integrated into the PATSCAN™ Multi-Sensor Threat Detection Platform, which also includes weapon detection, disturbance and fight detection modules.  The Health & Safety Modules use standard medium resolution thermal cameras, powered with the PATSCAN AI software to identify and analyze instances of elevated body temperature.  Any anomalous detection outside a nominal body temperature range will result in an immediate alert, which will be instantly transmitted to onsite security for further action.  In addition, Patriot One’s Xtract.ai division, in collaboration with Amazon Web Services, Vancouver General Hospital, University of British Columbia (“UBC”), and SapienML, helped radiologists identify the increased risk of the COVID19 virus.   This  project was led by Dr. Savvas Nicolaou and Dr. William Parker and supported by the UBC Community Health and Wellbeing Cloud Innovation Center (UBC-CIC) which has a mission to solve real-world challenges that materially benefit British Columbia and the world.  Data captured from CT and X-ray scans from around the world, are being reviewed and annotated by 4 radiologists, who are labelling each image to segment them into three classes: background, normal lung, and Ground Glass Opacity (“GGO”). The percentage of lung volume affected by GGO is a leading indicator for COVID-19, and the development of an automated approach to assess this can greatly assist medical practitioners to quickly diagnose early onset of the virus. Beyond the PATSCAN VRS modules highlighted above, Patriot One’s product and engineering teams have been hard at work on the development of the PATSCAN™ Multi-Sensor Gateway, which combines multiple sensors with select proprietary detection technologies into one gateway system.  As shared previously, by combining multiple sensors with the PATSCAN Artificial Intelligence neural network system (developed by the XTRACT.ai team), the Gateway’s overall performance level is dramatically enhanced and shows improved detection of personal concealed weapons..  The Patriot One product and engineering teams have been working side-by-side on the development and testing of the integrated Gateway solution. The result is a leading-edge, touchless detection technology that will save lives and modern society’s way of life. The PATSCAN™ Multi-Sensor Gateway will help protect on-site security, staff and visitors against weapons and other physical threats at building and venue entrances, as well as help identify potential viral threats with the addition of the thermal video recognition module. The PATSCAN™ Multi-Sensor Gateway (MSG 1.0) for Fastlane threat detection is planned for release to the North American market in August 2020 with several Gateway trial installations starting as early July 2020. In other news, Patriot One announces it has engaged Native Ads Inc. (“Native Ads”) to execute a comprehensive digital media marketing campaign for the Company.  This programmatic digital advertising campaign will run for 12 weeks for a total spend of US$120,000, including content creation, web development, media buying and distribution, advertising creative development, campaign reporting and optimization.Respectfully“Martin Cronin”Martin Cronin, CEOAbout Patriot One
Patriot Ones’ mission is to deliver innovative threat detection and counter-terrorism solutions for safer communities. Our PATSCAN™ Multi-Sensor Covert Threat Detection Platform provides a network of advanced sensor technologies with powerful next generation AI/machine learning software. The network can be covertly deployed from far perimeter to interiors across multiple weapons-restricted facilities. The PATSCAN™ platform identifies and reports threats wherever required; car park, building approach, employee & public entryways and inside the facilities. Each solution in the platform identifies weapons, related threats or disturbances, or potential health and safety threats for immediate security response. Our motto Deter, Detect and Defend is based on the belief that widespread use of the PATSCAN™ platform will act as an effective deterrent to diminish the epidemic of active threats around the globe. For more information, visit: www.patriot1tech.com or follow us on Twitter and Facebook.
About Native Ads
Native Ads is a full-service ad agency and operator of a programmatic ad exchange. Neither Native Ads, nor any of its directors and officers, own any securities of the Company.
For further information, please contact:Patriot One Inquiries
info@patriot1tech.com
www.patriot1tech.com
Investor Relations
John Martin, Patriot One                                   
+1 (888) 728-1332                                                                             
johnm@patriot1tech.com                                                                
Media Contacts:
Scott Ledingham, Patriot One                                          
+1-613-806-7135                                                                               
scott@prmedianow.com
CAUTIONARY DISCLAIMER STATEMENT:
No securities exchange has reviewed nor accepts responsibility for the adequacy or accuracy of the content of this news release. This news release contains forward-looking statements relating to system sales, product development, licensing, commercialization and regulatory compliance issues and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects”,” believes”, and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations include counterparty default and other risks detailed from time to time in the filings made by the Company with securities regulations. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements only as expressly required by applicable law.
Neither the Toronto Stock Exchange (TSX) nor its Regulation Services Provider (as that term is defined in policies of the TSX) accepts responsibility for the adequacy or accuracy of this release. 

Continue Reading

Trending

Roboticulized is part of PICANTE Media and Events, a leading media and boutique event organizer in the European Union with a monthly reach of +50,000 readers. The official company (PROSHIRT SRL), has been listed for 4 years in a row among the top 3 Advertising and market research agencies in the local Top Business Romania Microcompanies based on the Financial Reports. Roboticulized digests / hand picks the latest news about the AI industry and serves them to you daily.

Contact us: sales@picante.today

Editorial / PR Submissions

© Roboticulized.com 2019 - 2020 - part of PICANTE Media. All rights reserved. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania